Dr. Nancy Reid
Subclinical hypothyroidism (SCH) is a condition commonly diagnosed and treated in the primary care community. However, data is still lacking to support which groups of patients assume a benefit from treatment of SCH. The article below will briefly review the diagnosis of SCH, determining appropriate patients for treatment and primary benefits of treatment. In addition, populations will be identified as to whom may be effected negatively by starting or continuing treatment for SCH. Further, we will explore specific populations that fall into the “grey zone” of SCH, which we have defined as a TSH level of 7.0mU/L to 9.9mU/L. Suggestions will be presented as to how practitioners might decide which patients to treat in this “grey zone” and which to exclude, with an emphasis on consideration of individual cardiac risk.
David MT. Subclinical Hypothyroidism: Targeting Treatment to Maximize Therapeutic Outcomes. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2019; 1(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.